Ann Rheum Dis. 2010 Mar;69(3):503-9. doi: 10.1136/ard.2009.119149. Epub 2009 Oct 12.
3
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.